Main Profile

At A Glance

FDA Urges Caution Over Long-Term Use of Bone-Density-Building Drugs

Millions of women grapple with whether to take bone-density-building drugs to treat or prevent osteoporosis, but the FDA this week warned that long-term use of bisphosphonates can lead to rare fractures and side effects. Margaret Warner and Maine Medical Center's Dr. Clifford Rosen discuss the risks outlined by the FDA.
Length: 06:33

Contact

Questions about FDA Urges Caution Over Long-Term Use of Bone-Density-Building Drugs

Want more info about FDA Urges Caution Over Long-Term Use of Bone-Density-Building Drugs? Get free advice from education experts and Noodle community members.

  • Answer